WEBVTT

1
00:00:00.130 --> 00:00:02.149
This video describes the Xeomin

2
00:00:03.630 --> 00:00:04.429
(incobotulinumtoxinA) active

3
00:00:04.430 --> 00:00:06.249
ingredient manufacturing process

4
00:00:06.250 --> 00:00:08.229
and removal of complexing proteins

5
00:00:08.230 --> 00:00:10.230
from the active neurotoxin.

6
00:00:34.360 --> 00:00:35.919 line:85%
Xeomin's active ingredient is

7
00:00:35.920 --> 00:00:37.259 line:85%
derived from Hall-Strain

8
00:00:37.260 --> 00:00:39.179 line:85%
Clostridium botulinum serotype

9
00:00:39.180 --> 00:00:41.079 line:85%
A. But the difference is

10
00:00:41.080 --> 00:00:43.059 line:85%
in how the active neurotoxin is

11
00:00:43.060 --> 00:00:43.859 line:85%
purified.

12
00:00:43.860 --> 00:00:45.479 line:85%
Through state-of-the-art extract

13
00:00:45.480 --> 00:00:47.779 line:85%
technology, the active neurotoxin

14
00:00:47.780 --> 00:00:49.719 line:85%
in Xeomin is isolated, using

15
00:00:49.720 --> 00:00:51.299 line:85%
the multi-step process of

16
00:00:51.300 --> 00:00:52.959 line:85%
chromatography that uniquely

17
00:00:52.960 --> 00:00:54.979 line:85%
purifies the molecule, removing

18
00:00:54.980 --> 00:00:57.059
the complexing proteins, leaving

19
00:00:57.060 --> 00:00:58.839
just the active therapeutic

20
00:00:58.840 --> 00:00:59.840
components.